These patients include 21 with brain metastases (cases) and 21 controls without brain metastases (but with metastases to other organs such as bone) that were selected to have matched age, time from diagnosis, and HER2/ER/PR status of the breast tumor. This evidence concerns the gene ERBB2 and breast neoplasm.